NeurologyLive® Friday 5 — May 5, 2023

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive^®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Early Identification and Personalized Care in Spinal Muscular Atrophy: Insights From Brazil

In this feature from our April print edition, experts review the state of SMA diagnosis and medications, highlighting factors that guide treatment selection in North America and South America.

2: Peer Exchange: Generic Disease-Modifying Therapies (DMTs) in RRMS

In episode 3 of this Peer Exchange series on "The Shifting Treatment Landscape of RRMS", expert neurologists review the availability of generic disease-modifying therapies [DMTs] and the effectiveness of reduced cost to the patient with RRMS.

3: NeuroVoices: John Hey, PhD, on ALZ-801’s Impact on Alzheimer Biomarkers, P-Tau181

In the latest edition of our in-depth Q&A series, the chief scientific officer at Alzheon discussed new, positive 12-month findings on ALZ-801, an investigational agent in development for patients with early-stage Alzheimer disease.

4: AAN Annual Meeting 2023: Top Expert Interviews

A group of experts in the care of patients with neurological conditions—Ali Jannati, MD, PhD; Madhav R. Thambisetty, MD, PhD; Daniel Ontaneda, MD, PhD; Peter J. Goadsby, MD, PhD, DSc; Andrew Russman, DO—shared their perspectives on hot topics of treatment and management in neurology from the 2023 American Academy of Neurology Annual Meeting.

5: Neurology News Network: Shared Decision-Making In Parkinson Disease Care

In this episode of Neurology News Network, Stuart H. Isaacson, MD, FAAN, an expert in the management of Parkinson disease, discusses the key role that shared decision-making plays in the modern treatment paradigm.